regulatory · primary record
Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval Management; Draft Guidance for Industry; Availability
Health and Human Services Department · US · 2026-10-28
| Regulator | Health and Human Services Department |
|---|---|
| Jurisdiction | US |
| Type | notice |
| Date | 2026-10-28 |
| Deadline | 2026-11-27 |
| Industries | healthcare-life-sciences |
Provenance
- Source: Health and Human Services Department
- Fetched at: 2026-10-28T10:40:41.762Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: 2026-21954
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.